MedPath

Social Cognition Individualized Activities Lab (SoCIAL) - cognitive training in Borderline Personality Disorder: a pilot study

Not Applicable
Recruiting
Conditions
borderline personality disorder
Mental Health - Psychosis and personality disorders
Registration Number
ACTRN12624000144516
Lead Sponsor
niversity of Turin
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
60
Inclusion Criteria

Consecutive (18-60 years), outpatients with a diagnosis of BPD according to DSM-5 criteria will be enrolled.
The diagnosis is made by evaluation by experienced clinicians and by administration of SCID-5 (Structured Clinical Interview for DSM-5 personality disorders).

Exclusion Criteria

a) presence of neuropsychiatric comorbidities, assessed according to DSM-5 criteria and including: neurodevelopmental disorders; neurocognitive disorders; schizophrenia and schizophrenic spectrum disorders; bipolar disorder
b) concomitant major depressive episode and/or active substance use;
c) symptomatological severity judged by the clinician to be incompatible with the intervention setting

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Primary outcome: any change in social cognition skills, assessed using Reading the Mind in the Eyes Test (RMEIT) and Facial Emotion Identification Test (FEIT). [ Recruited patients and control subjects will be evaluated at baseline (t0) and at 10 weeks post enrolment<br>(t1).];Primary outcome: any change in narrative coherence, assessed with Narrative Coherence Coding Scheme (NaCCS).[ Recruited patients and control subjects will be evalueted at baseline (t0) and at 10 weeks post enrolment (t1)]
Secondary Outcome Measures
NameTimeMethod
Secondary outcomes: Any change at psychometric scales assessing severity of symptoms assessed using Borderline Personality Disorder Severity Index-IV (BPDSI-IV) and Clinical Global Impression Severity (CGI-S); [ Recruited patients and control subjects will be evaluated at baseline (t0) and at 10 weeks post enrolment<br>(t1).];Secondary outcomes: Any change at psychometric scales assessing social and global functioning assessed using Occupational Functioning Assessment Scale (SOFAS);[ Recruited patients and control subjects will be evaluated at baseline (t0) and at 10 weeks post enrolment (t1).];Secondary outcomes: Any change at psychometric scales assessing cognitive abilities assessed using Screen for cognitive impairment in psychiatry (SCIP).[ Recruited patients and control subjects will be evaluated at baseline (t0) and at 10 weeks post enrolment (t1).]
© Copyright 2025. All Rights Reserved by MedPath